EHEC 的新型粘附因子研究进展*

摘要：肠出血性大肠杆菌（enterohemorrhage ，EHEC）是一种重要的人畜共患病，世界各地包括中国都有不同规模的暴发流 行。EHEC有多种血清型，其中毒力最强血清型是O157：H7。EHEC O157：H7 感染除可使人发生常规腹泻外，还可在5%-10%的病 例中引发严重并发症，甚至死亡。该菌是重要的食源性致病菌，危害严重，缺乏有效的防治手段，而抗生素治疗可能会加剧溶血性 尿毒症（haemolutic uraemic syndrome，HUS）。由于以上特点EHEC O157：H7 成为世界公共卫生问题，引起微生物学家和公共卫生 工作者的广泛关注。目前，临床针对EHEC 感染只是对症治疗和适当的抗菌治疗。粘附是EHEC感染宿主细胞的第一步，没有这 一步，细菌和宿主肠道细胞之间不会发生任何的相互作用，而且对于许多病原菌来说，粘附具有宿主特异性。本文概述了EHEC 的流行病学及粘附机理，并对近年在EHEC 研究中的发现一些新型粘附因子和一些假设的定植因子的研究背景及作用机理作一 综述。     

大肠杆菌O157:H7致病因子及其保护性免疫研究现状

大肠杆菌O157:H7是肠出血型大肠杆菌(EHEC)的主要病原血清型,它可产生特殊的粘附因子粘附靶细胞,产生Vero毒素和肠溶血素毒力因子.近几年对大肠杆菌O157:H7的毒力因子有了深入的了解,对致病机理作了一些探讨,用实验动物对保护性免疫进行了研究.本文对近几年来0157:H7大肠杆菌的致病因子及其主要的保护性免疫的研究作一简要综述.     

肠出血性大肠杆菌Ⅲ型分泌系统及其转位效应器蛋白质

肠出血性大肠杆菌(enterohemorrhagic Escherichia coli,EHEC)0157:H7是一种重要的肠道病原微生物,感染后可引发多种疾病,严重者可导致死亡.EHEC O157:H7通过Ⅲ型分泌系统(TTSS)将其转位效应器蛋白质转位至宿主细胞,经一系列的信号传导过程介导与宿主细胞的"黏附与擦拭"(attaching and effacing,A/E)损伤.对EHEC0157:H7 Ⅲ型分泌系统及其转位效应器蛋白质进行研究,可使我们进一步认识EHEC以及引起A/E损伤的病原菌的致病机理,丰富有关Ⅲ型分泌系统和致病岛的知识.     

大肠杆蓖O157：H7致病因子及其保护性免疫研究现状

大肠杆菌O157：H7是肠出因型大肠杆菌（EHEC）的主要病原血清型,它可产生特殊的粘附因子粘附靶细胞,产生Vero毒素和肠溶血素毒力因子。近几年对大肠杆菌O157：H7的毒力因子有了深入的了解,对致病机理作了一些探讨,用实验动物对保护性免疫进行了研究。本文对近几年来O157：H7大肠杆菌的致病因子及其主要的保护性免疫的研究作一简要综述。     

肠出血性大肠杆菌O157∶H7 EspA和EspB蛋白的重组表达及其免疫效果

目的：通过DNA重组技术表达肠出血性大肠杆菌（EHEC）0157：H7的EspA和EspB蛋白,并分析它们的免疫保护性。方法：采用PCR技术从EHEC0157：H7基因组中扩增espA和espB基因,连接至pET-22b（4-）载体上,转化至宿主细胞大肠杆菌BL21（DE3）,经IPTG诱导表达,用亲和层析纯化目的蛋白,SDS-PAGE测定其相对分子质量,免疫小鼠分析其免疫保护性。结果：重组espA和espB基因片段的测序结果与GenBank中的相应基因序列完全一致,一致性均为100％;得到了纯度为95％以上的重组EspA和EspB蛋白,免疫小鼠所得到的抗体效价均为10^6。结论：重组EspA和EspB蛋白获得了可溶性表达,表达的蛋白具有良好的免疫保护性,为进一步制备疫苗奠定了基础。     

白色念珠菌粘附的研究进展

本文论述了白色念珠菌（简称白念菌）粘附的分子机理和实验模型观察,从病原菌和宿主两方面探讨了白念菌感染的发病机理,并从阻断白念菌对宿主细胞的粘附着手,展望防治白念菌感染的新途径和措施。     

肺炎链球菌粘附机制的研究现状

肺炎链球菌粘附宿主我肺炎链球菌侵袭、感染宿主细胞的先决条件。粘附过程是特异的,是细菌表面的粘附分子和宿主细胞膜受体相互作用的结果。英膜对肺炎链球菌的粘附无影响,而细胞壁（ＣＷ）在介导肺炎链附粘附宿主细胞过程中起重要作用;ＣＷ亚组人脂磷酸（ＬＴＡ）介导肺炎链球菌的粘附过程,并导致炎症反应;细菌表面的结构蛋白或分泌蛋白是细菌与宿主细胞连接的桥梁;肺炎链球菌能与宿主细胞外基质蛋白特异性结合,进而粘附宿主     

肺炎链球菌致病机理的最新研究进展

肺炎链球菌致病过程包括粘附 ,炎症反应 ,细菌产物的细胞毒作用。阻止肺炎链球菌粘附到宿主细胞受体和定植在粘膜表面 ,是预防其感染的最有效的途径。综述了肺炎链球菌粘附过程的最新研究进展和肺炎链球菌毒力因子及其可能的致病机理 ,对研制新一代疫苗 ,预防和治疗肺炎链球菌感染有重要意义。     

细菌粘附素的分子结构和装配机制

细菌感染的第一步是必须粘附于易感细胞,以获得立足点,在局部繁殖,释放毒素和酶类损坏组织,导致感染,细菌的粘附作用主要靠粘附素特异的识别结合到宿主细胞的受体,使细胞在局部定居,本文主要综述菌毛粘附素的分子结构及其因控制,菌毛粘附素如何通过四种典型途径装配,以及参与装配的蛋白质是如何协调功能的研究进展。     

肠出血性大肠杆菌Ⅲ型分泌系统效应因子与宿主细胞相互作用研究进展

肠出血性大肠杆菌(Enterohemorrhagic Escherichia coli,EHEC)通过其Ⅲ型分泌系统将效应因子注入到宿主细胞内,破坏宿主细胞内的多种信号通路从而有利于细菌的感染及定植。近年来对于EHEC Ⅲ型分泌系统效应因子与宿主细胞相互作用研究成为EHEC致病机制研究新的热点,研究表明,除了经典的效应因子外,一些新发现的效应因子在细菌的致病过程中也发挥着重要作用,有些效应因子能够抑制宿主细胞内正常的信号通路,有些效应因子还具有抑制细胞凋亡,干扰炎症信号通路和抑制吞噬的作用。这些发现揭示了EHEC效应因子具有多种功能,它们通过与宿主细胞间的相互作用,在细菌的感染过程中发挥着重要作用。     

大肠杆菌O157:H7的sRNA伴侣蛋白Ufq的基因克隆、表达及纯化

目的:克隆、表达并纯化肠出血性大肠杆菌(EHEC)O157:H7的sRNA伴侣蛋白Hfq.方法:利用PCR方法从EHEC O157:H7基因组中扩增出基因hfq,并插入含6xHis标签序列的原核表达载体pET28a(+)的多克隆位点中,构建重组表达质粒pET28a(+)-hfq,以重组质粒转化大肠杆菌BL21(DE3)...     

用含10%胎牛血清的DMEM培养肠出血性大肠杆菌O157∶H7可增强其对HeLa细胞的黏附/擦拭损伤

目的:研究生长在不同培养基中的肠出血性大肠杆菌(EHEC)O157∶H7对宿主细胞造成的黏附/擦拭损伤是否存在差异。方法:分别用LB、DMEM、DMEM(含10%胎牛血清)、DMEM(含终浓度为25mmol/L的HEPES)等4种培养基培养O157∶H7,然后感染HeLa细胞,利用Giemsa染色观察细菌黏附差异,进行肌动蛋白荧光染色实验并观察宿主细胞肌动蛋白聚集差异。结果:在含10%胎牛血清的DMEM培养基中培养EHECO157∶H7,其黏附力增加,聚集细胞骨架肌动蛋白的能力明显增强。结论:为进一步研究EHECO157∶H7的致病性,探索O157∶H7新的致病因子奠定了基础。     

TaqMan探针荧光PCR检测肠出血性大肠埃希菌O157:H7方法的建立

肠出血性大肠埃希菌(Enterohemorrhagie Escherichia coli,EHEC)O157:H7是一种重要的传染病病原菌,以EHEC O157:H7标准菌株rfbE保守区设计一对特异引物和一条探针,建立了检测EHEC O157:H7核酸的荧光定量PCR检测方法。实验结果表明荧光定量PCR检测方法特异性好,最低检测限为20 cfu/mL,线性范围是102～108cfu/mL。稳定性试验表明批内变异系数和批间变异系数分别为2.06%和2.45%。     

Avian- and mammalian-derived antibodies against adherence-associated proteins inhibit host cell colonization by Escherichia coli O157:H7

AIM: To evaluate the potential for polyclonal antibodies targeting enterohaemorrhagic Escherichia coli (EHEC) virulence determinants to prevent colonization of host cells by E. coli O157:H7. METHODS AND RESULTS: Rats and laying hens were immunized with recombinant proteins from E. coli O157:H7, EspA, C-terminal intimin or EscF. Rat antisera (IgG) or chicken egg powders (IgY) were assessed for their ability to inhibit growth and colonization-associated processes of E. coli O157:H7. Mammalian antisera with antibodies to intimin, EspA or EscF effectively reduced adherence of the pathogen to HeLa cells (P<0.05) and prevented type III secretion of Tir. Similarly, HeLa cells treated with chicken egg powder containing antibodies against intimin or EspA were protected from EHEC adherence (P<0.05). Neither egg nor rat antibody preparations had any antibacterial effect on the growth of EHEC (P>0.05). CONCLUSIONS: Antibody preparations targeting EHEC adherence-associated factors were effective at preventing adhesion and intimate colonization-associated events. SIGNIFICANCE AND IMPACT OF THE STUDY: This work indicates that immunotherapy with anti-adherence antibodies can reduce E. coli O157:H7 colonization of host cells. Passive immunization with specific antibodies may have the potential to reduce E. coli O157:H7 colonization in hosts such as cattle or humans.     

Surface-layer protein extracts from Lactobacillus helveticus inhibit enterohaemorrhagic Escherichia coli O157:H7 adhesion to epithelial cells

Adherence of intestinal pathogens, including Escherichia coli O157:H7, to human intestinal epithelial cells is a key step in pathogenesis. Probiotic bacteria, including Lactobacillus helveticus R0052 inhibit the adhesion of E. coli O157:H7 to epithelial cells, a process which may be related to specific components of the bacterial surface. Surface-layer proteins (Slps) are located in a paracrystalline layer outside the bacterial cell wall and are thought to play a role in tissue adherence. However, the ability of S-layer protein extract derived from probiotic bacteria to block adherence of enteric pathogens has not been investigated. Human epithelial (HEp-2 and T84) cells were treated with S-layer protein extract alone, infected with E. coli O157:H7, or pretreated with S-layer protein extract prior to infection to determine their importance in the inhibition of pathogen adherence. The effects of S-layer protein extracts were characterized by phase-contrast and immunofluorescence microscopy and measurement of the transepithelial electrical resistance of polarized monolayers. Pre-treatment of host epithelial cells with S-layer protein extracts prior to E. coli O157:H7 infection decreased pathogen adherence and attaching-effacing lesions in addition to preserving the barrier function of monolayers. These in vitro studies indicate that a non-viable constituent derived from a probiotic strain may prove effective in interrupting the infectious process of an intestinal pathogen.     

A carboxy-terminal domain of Tir from enterohemorrhagic Escherichia coli O157:H7 (EHEC O157:H7) required for efficient type III secretion

The type III secreted protein Tir from Enterohemorrhagic Escherichia coli (EHEC O157:H7) plays a central role in adherence and pedestal formation during infection. Little is known about how Tir domains outside of the amino-terminus contribute to efficient Tir secretion and translocation. We found a 6 amino acid (519-524) carboxy-terminal region which was required for efficient Tir secretion and translocation. Interestingly, EHEC O157:H7 Tir(Delta)519-524 was efficiently secreted when expressed in the related pathogen enteropathogenic E. coli. These data suggest that this region may play a role in maintaining EHEC O157:H7 Tir in a secretion-competent conformation.     

Lipopolysaccharide O-antigen of enterohemorrhagic Escherichia coli O157:H7 is required for killing both insects and mammals

Studies of enterohemorrhagic Escherichia coli (EHEC) infection mechanisms using mammals require large numbers of animals and are both costly and associated with ethical problems. Here, we evaluated the pathogenic mechanisms of EHEC in the silkworm model. Injection of a clinically isolated EHEC O157:H7 Sakai into either the silkworm hemolymph or intraperitoneal fluid of mice killed the host animals. EHEC O157:H7 Sakai deletion mutants of the rfbE gene, which encodes perosamine synthetase, a monosaccharide component synthetase of the O-antigen, or deletion mutants of the waaL gene, which encodes O-antigen ligase against the lipid A-core region of lipopolysaccharide (LPS), had attenuated killing ability in both silkworms and mice. Introduction of the rfbE gene or the waaL gene into the respective mutants restored the killing ability in silkworms. Growth of both mutants was inhibited by a major antimicrobial peptide in the silkworm hemolymph, moricin. The viability of both mutants was decreased in swine serum. The bactericidal effect of swine serum against both mutants was inactivated by heat treatment. These findings suggest that the LPS O-antigen of EHEC O157:H7 plays an important defensive role against antimicrobial factors in the host body fluid and is thus essential to the lethal effects of EHEC in animals.